NEW YORK (TheStreet
) -- CHANGE IN RATINGS
ATVI rated new Outperform at Credit Suisse. $16 price target. Company can continue to expand around the globe.
CELG downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $86 price target. Company lacks near-term catalysts.
CHKP downgraded at Needham from Buy to Hold, Needham said. Recent field checks suggest that sales could slow down in the coming quarters.
COT rated new Buy at Citigroup. $10 price target. Strong EPS growth driven by a balance of factors.
CVX rated new Hold at Dahlman. Two major LNG projects add risk to the thesis.
DHI downgraded at MKM from Buy to Neutral, MKM Partners said. Valuation call, as the sector has already made a big run.
ERTS rated new Neutral at Credit Suisse. $16 price target. Company has struggled with its digital transition.
FDX upgraded at Standpoint from Hold to Buy, Standpoint said. $130 price target. Company is cutting costs and annual earnings can approach $10 a share.
GHDX rated new Neutral at Goldman. $36 price target. Company has limited earnings upside potential.
HST downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Expect slower industry RevPAR growth.
JCI downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Management will struggle to turn the company around by 2013.
LEN downgraded at MKM from Buy to Neutral, MKM Partners said. See limited upside to near-term earnings expectations.
MAR downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock has outperformed the market year-to-date.
PCS downgraded at Oppenheimer to Underperform from Perform, Oppenheimer said. Wireless to eventually consolidate into three players.
RAD rated new Buy at BTIG. $2.25 price target. Company is improving customer retention and margins.
TXN downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $26 price target. Company is leveraged to slower macro growth.
XOM rated new Buy at Dahlman. $100 price target. Company will continue to buy back stock in the coming quarters.
ZNGA rated new Underperform at Credit Suisse. $3 price target. Company is losing customers, even for new games.
STOCK COMMENTS / EPS CHANGES
ADTN numbers lowered at Jefferies.
Shares of ADTN now seen reaching $13.25, Jefferies said. Estimates also lowered on ugly Q3. Underperform rating.
DF numbers cut at UBS.
Shares of DF now seen reaching $15.50, UBS said. Estimates also lowered on heightened dairy input cost pressure. Neutral rating.
FDX target raised at Citigroup to $108, Citigroup said. EBIT improvement target supports above consensus estimates. Buy rating.
IACI numbers raised at Oppenheimer.
Shares of IACI now seen reaching $67, Oppenheimer said. Estimates also raised on numerous catalysts. Outperform rating.
LLY target boosted at BofA/Merrill to $57, according to Bank of America/Merrill Lynch said. Sola should ultimately reach the market for Alzheimer's. Buy rating.
LYB estimates raised at UBS through 2013, UBS said. Improved refining partially offsets weaker European OPO. Neutral rating and $49 price target.
PGR estimates, target raised at KBW.
Shares of PGR now seen reaching $21, according to Keefe, Bruyette & Woods. Estimates also increased, given higher realized premium growth. Market Perform rating.
UHS numbers raised at Credit Suisse.
Shares of UHS now seen reaching $53, according to Credit Suisse. Estimates also increased, as the Ascend deal should add to earnings. Outperform rating.
YUM numbers raised at UBS.
Shares of YUM now seen reaching $84, UBS said. Estimates also increased on higher unit growth in China. Buy rating.
YUM! Brands numbers raised at Jefferies.
Shares of YUM now seen reaching $70, Jefferies said. Estimates also raised on solid EPS beat. Hold rating.
>To submit a news tip, email: email@example.com
READERS ALSO LIKE:
and become a fan on Facebook.
For less than $3 per week, you can get full access to Jim Cramer's intraday market commentary and stock trading strategies - sometimes before he says them on TV! Join now.